Sedana Medical AB (OSTO:SEDANA) Tax Expense: kr2.3 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:SEDANA Sedana Medical AB OSTO:SEDANA
69 GF Score
Price kr9.80
GF Value kr17.42
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Sedana Medical AB Tax Expense?

Sedana Medical AB OSTO:SEDANA -1.01% 69 Tax Expense is kr2.3 Mil as of Jun. 2026. GuruFocus rates OSTO:SEDANA with a GF Score™ of 69/100 and a GF Value™ of kr17.42 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Sedana Medical AB's tax expense for the months ended in Jun. 2026 was kr1.1 Mil. Its tax expense for the trailing twelve months (TTM) ended in Jun. 2026 was kr2.3 Mil.


Sedana Medical AB  (OSTO:SEDANA) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Sedana Medical AB Tax Expense Related Terms


Sedana Medical AB Tax Expense Historical Data

* Premium members only.

The historical data trend for Sedana Medical AB's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sedana Medical AB Tax Expense Chart

Sedana Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.60 0.57 0.59 0.73 1.98

Sedana Medical AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.37 0.49 0.14 0.51 1.11
OSTO:SEDANA
69GF Score
Sedana Medical AB OSTO:SEDANA
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sedana Medical AB Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr2.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of kr2.3 Mil mean?
Sedana Medical AB (OSTO:SEDANA) has a Tax Expense of kr2.3 Mil as of Jun. 2026. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Sedana Medical AB and its competitors.
Is Sedana Medical AB's Tax Expense too high?
Sedana Medical AB's current Tax Expense is kr2.3 Mil. Overall, Sedana Medical AB has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sedana Medical AB's Tax Expense compare to ABT and SYK?
Sedana Medical AB's Tax Expense of kr2.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Medical Devices & Instruments company?
A good Tax Expense depends on the Medical Devices & Instruments industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Sedana Medical AB and its competitors. Sedana Medical AB's current Tax Expense is kr2.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sedana Medical AB stock overvalued right now?
Based on GuruFocus' analysis, Sedana Medical AB (OSTO:SEDANA) is currently considered Significantly Undervalued. The stock's GF Value™ is kr17.42, compared to a current price of kr9.80 — trading 43.7% below its estimated fair value. The current Tax Expense is kr2.3 Mil. Sedana Medical AB's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Sedana Medical AB (OSTO:SEDANA), the current Tax Expense is kr2.3 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sedana Medical AB (OSTO:SEDANA) Overvalued in 2026?

Based on GuruFocus' analysis, Sedana Medical AB stock appears to be undervalued. The current stock price of kr9.80 is trading 43.7% below its estimated GF Value™ of kr17.42. GuruFocus considers Sedana Medical AB to be Significantly Undervalued.

Key valuation signals for OSTO:SEDANA:

  • Tax Expense: kr2.3 Mil
  • GF Value™: kr17.42 vs. price of kr9.80 (43.7% below fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the OSTO:SEDANA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sedana Medical AB Business Description

Other Exchanges 7D2A:Germany
Address Svardvagen 3A, Danderyd, SWE, SE-182 33
Sedana Medical AB is a Sweden-based medical technology company. It is ais a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient's life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care. Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, and Spain. In other parts of Europe, as well as in Asia, Australia, Canada, and South and Central America, the company works with external distributors.
69GF Score

Get the complete analysis for OSTO:SEDANA

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr9.80
Price
kr17.42
GF Value